Source: iQoncept / Shutterstock
TFF Pharmaceuticals (NASDAQ:TFFP) recently unveiled its Q4 2023 earnings.
- TFF Pharmaceuticals defied expectations with an earnings per share of -$2.01, surpassing the projected EPS of -$2.12.
- The company soared with a revenue of $114,328, outperforming the anticipated revenue of $100,000 by 14.33%.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tffp-stock-earnings-tff-pharmaceuticals-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC
